Role of T Lymphocytes in Hypertension

Overview

Journal Curr Opin Pharmacol

Specialty Pharmacology

Date 2014 Dec 20

PMID 25523165

Citations 45

Authors

Jiandong Zhang

Steven D Crowley

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence indicates that the immune system plays a critical role in the pathogenesis of cardiovascular diseases including hypertension. Mice lacking T lymphocytes are resistant to blood pressure elevation, suggesting a key contribution of T lymphocytes to hypertension. However, the individual T cell subsets, including CD8(+), Th1, Th17, and T regulatory T cells have shown widely discrepant effects on blood pressure and target organ damage in this disorder. Moreover, the activation state of a T lymphocyte population exerts considerable influence over its role in hypertension. In turn, activated T cells regulate blood pressure through the elaboration of reactive oxygen species and vasoactive cytokines, altering the inflammatory milieu in the vascular wall and the kidney. Recent GWAS studies similarly point to a role for T lymphocytes in human hypertension.

Citing Articles

Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced therapeutic potential.

Thakkar B, Dadhaniya H, Dudhat K Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39888363 DOI: 10.1007/s00210-025-03819-3.

Gender differences in the relationship between the systemic immune-inflammation index and all-cause and cardiovascular mortality among adults with hypertension: evidence from NHANES 1999-2018.

Cheng T, Yu D, Tang Q, Qiu X, Li G, Zhou L Front Endocrinol (Lausanne). 2024; 15:1436999.

PMID: 39439560 PMC: 11493643. DOI: 10.3389/fendo.2024.1436999.

PVAT-conditioned media from Dahl S rats on high fat diet promotes inflammatory cytokine secretion by activated T cells prior to the development of hypertension.

Jin Y, Liu S, Guzman K, Kumar R, Kaiser L, Garver H PLoS One. 2024; 19(10):e0302503.

PMID: 39361560 PMC: 11449284. DOI: 10.1371/journal.pone.0302503.

HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps.

Prakash P, Swami Vetha B, Chakraborty R, Wenegieme T, Masenga S, Muthian G Circ Res. 2024; 134(11):e150-e175.

PMID: 38781298 PMC: 11126208. DOI: 10.1161/CIRCRESAHA.124.323979.

Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.

Xia Y, Gao D, Wang X, Liu B, Shan X, Sun Y Front Immunol. 2024; 15:1331609.

PMID: 38558816 PMC: 10978666. DOI: 10.3389/fimmu.2024.1331609.

References

Kasal D, Barhoumi T, Li M, Yamamoto N, Zdanovich E, Rehman A . T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2011; 59(2):324-30. DOI: 10.1161/HYPERTENSIONAHA.111.181123. View

Bautista L, Vera L, Arenas I, Gamarra G . Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2004; 19(2):149-54. DOI: 10.1038/sj.jhh.1001785. View

Zhu J, Paul W . CD4 T cells: fates, functions, and faults. Blood. 2008; 112(5):1557-69. PMC: 2518872. DOI: 10.1182/blood-2008-05-078154. View

Fernandez-Real J, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J . Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab. 2001; 86(3):1154-9. DOI: 10.1210/jcem.86.3.7305. View

Guzik T, Hoch N, Brown K, McCann L, Rahman A, Dikalov S . Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007; 204(10):2449-60. PMC: 2118469. DOI: 10.1084/jem.20070657. View

HEPTINSTALL R . Renal biopsies in hypertension. Br Heart J. 1954; 16(2):133-41. PMC: 479508. DOI: 10.1136/hrt.16.2.133. View

Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker R . Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013; 496(7446):518-22. PMC: 3746493. DOI: 10.1038/nature11868. View

Gratze P, Dechend R, Stocker C, Park J, Feldt S, Shagdarsuren E . Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation. 2008; 117(20):2645-56. DOI: 10.1161/CIRCULATIONAHA.107.760116. View

Madhur M, Lob H, McCann L, Iwakura Y, Blinder Y, Guzik T . Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2009; 55(2):500-7. PMC: 2819301. DOI: 10.1161/HYPERTENSIONAHA.109.145094. View

10.

Herrera J, Ferrebuz A, MacGregor E, Rodriguez-Iturbe B . Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006; 17(12 Suppl 3):S218-25. DOI: 10.1681/ASN.2006080918. View

11.

Wenzel P, Knorr M, Kossmann S, Stratmann J, Hausding M, Schuhmacher S . Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation. 2011; 124(12):1370-81. DOI: 10.1161/CIRCULATIONAHA.111.034470. View

12.

James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

13.

Chen Z, OShea J . Regulation of IL-17 production in human lymphocytes. Cytokine. 2007; 41(2):71-8. PMC: 11225033. DOI: 10.1016/j.cyto.2007.09.009. View

14.

Ates I, Ozkayar N, Akyel F, Topcuoglu C, Akyel S, Barca A . The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients. BMC Nephrol. 2014; 15:159. PMC: 4190353. DOI: 10.1186/1471-2369-15-159. View

15.

Crowley S, Frey C, Gould S, Griffiths R, Ruiz P, Burchette J . Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol. 2008; 295(2):F515-24. PMC: 2519187. DOI: 10.1152/ajprenal.00527.2007. View

16.

Lozovoy M, Simao A, Morimoto H, Iryioda T, Panis C, Reiche E . Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress. Scand J Rheumatol. 2013; 43(1):59-62. DOI: 10.3109/03009742.2013.834963. View

17.

Crowley S, Song Y, Lin E, Griffiths R, Kim H, Ruiz P . Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010; 298(4):R1089-97. PMC: 4422347. DOI: 10.1152/ajpregu.00373.2009. View

18.

Ng H, Burris R, Nagarajan S . Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells. J Immunol. 2011; 187(11):6082-93. PMC: 3221885. DOI: 10.4049/jimmunol.1004133. View

19.

Ait-Oufella H, Salomon B, Potteaux S, Robertson A, Gourdy P, Zoll J . Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006; 12(2):178-80. DOI: 10.1038/nm1343. View

20.

Didion S, Kinzenbaw D, Schrader L, Chu Y, Faraci F . Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension. 2009; 54(3):619-24. PMC: 2861503. DOI: 10.1161/HYPERTENSIONAHA.109.137158. View